Wentworth-Douglass Hospital is a clinical research site located in Dover, New Hampshire, United States 03820.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Wentworth-Douglass Hospital has participated in 39 clinical trials with 19 currently active.
Therapeutic areas: Plasma Cell Myeloma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.
Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), NRG Oncology.
Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Wentworth-Douglass Hospital has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Wentworth-Douglass Hospital has 39 clinical trials on record, with 19 currently active. Their work covers Plasma Cell Myeloma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.
Wentworth-Douglass Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.